Related Experiment Video
Updated: Mar 15, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Conformational changes associated with L16P and T118M mutations in the membrane-embedded PMP22 protein, consequential
Martiniano Bello1, Mixtli J Torres2, Alfonso Méndez-Tenorio2
1a Laboratorio de Modelado Molecular y Bioinformática de la Escuela Superior de Medicina , Instituto Politécnico Nacional , Plan de San Luis Y Diaz Mirón S/N, Col. Casco de Santo Tomas, Ciudad de México C.P. 11340 , México.
Abstract:
Peripheral myelin protein 22 (PMP22) resides in the plasma membrane and is required for myelin formation in the peripheral nervous system. Excess PMP22 mutants accumulate in the endoplasmic reticulum (ER) resulting in the inherited neuropathies of Charcot-Marie-Tooth disease. However, there was no evidence of the structure of PMP22 or how mutations affect its folding. Therefore, in this study, we combined bioinformatics and homology modeling approaches to obtain three-dimensional native and mutated PMP22 models and its anchoring to a POPC membrane, submitted to .5-μs MD simulations, to determine how the L16P and T118M mutations affect the conformational behavior of PMP22. In addition, we investigated the ability of the native and mutated species to accumulate in the ER, via interaction with RER1, by combining protein-protein docking and MD simulations, taking the conformations that were most representative of the native and mutated PMP22 systems and RER1 conformations. Principal component analysis over MD simulations revealed that L16P and T118M mutations resulted in increased structural instability compared to the native form, which is consistent with previous experimental findings of increased structural fluctuations along a loop connecting transmembrane α-helix1 and α-helix2. Docking and MD simulations coupled with the MMGBSA approach allowed the identification that the binding interface for the PMP22-RER1 complex takes place through transmembrane α-helix1 and α-helix2, with higher effective binding free energy values between the mutated PMP22 systems and RER1 than for the native PMP22, mainly through van der Waals interactions.
Insights
Mutations in peripheral myelin protein 22 (PMP22) cause Charcot-Marie-Tooth disease by increasing protein instability and ER accumulation. This study modeled PMP22 structure and its interaction with RER1 to understand disease mechanisms.
Area of Science:
- Biophysics
- Neuroscience
- Structural Biology
Background:
- Peripheral myelin protein 22 (PMP22) is crucial for peripheral nervous system myelin formation.
- PMP22 mutations lead to endoplasmic reticulum (ER) accumulation and Charcot-Marie-Tooth disease (CMT).
- The structural basis of PMP22 mutations and their ER retention mechanism remained unclear.
Purpose of the Study:
- To determine the structural impact of PMP22 mutations (L16P and T118M) on protein conformation and stability.
- To investigate how these mutations affect PMP22's interaction with RER1, leading to ER accumulation.
Main Methods:
- Bioinformatics and homology modeling to generate 3D PMP22 models.
- Molecular dynamics (MD) simulations to analyze conformational behavior and membrane anchoring.
- Protein-protein docking and MD simulations to study PMP22-RER1 interactions.
Main Results:
- L16P and T118M mutations increase PMP22 structural instability and fluctuations.
- Mutated PMP22 exhibits enhanced binding to RER1 via transmembrane helices.
- Higher binding free energy between mutated PMP22 and RER1 suggests increased ER retention.
Conclusions:
- PMP22 mutations destabilize the protein structure, consistent with experimental data.
- Mutated PMP22 shows increased affinity for RER1, explaining ER accumulation in CMT.
- Structural insights provide a basis for understanding PMP22-related neuropathies.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Abnormal Proliferation
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Point and Frameshift Mutations

